SEC Form 4 · accession 0001179110-17-003019
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anna Berkenblit
Officer — VP & Chief Medical Officer
Period of report
Feb 22, 2017
Accepted (ET)
Feb 23, 2017 · 3:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 21, 2017 | A | 157,300 | $2.47 | A | 163,300 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are restricted stock which vest annually in three equal installments commencing on February 21, 2018.